ARCA Biopharma Inc (NASDAQ:ABIO)
| 0.70 Delayed Data As of Feb 27 |  -0.09 / -11.39%Today’s Change | 0.65 Today|||52-Week Range 2.38 | -26.59% Year-to-Date |
Latest ABIO News | Press Releases
No recent news for ARCA Biopharma Inc.
Today’s Trading
| Previous close | 0.79 |
| Today’s open | 0.84 |
| Day’s range | 0.70 - 0.84 |
| Volume | 1,038,054 |
| Average volume (3 months) | 400,205 |
| Market cap | $14.8M |
| Dividend yield | -- |
Data as of 3:59pm ET, 02/27/2015
Growth & Valuation
| Earnings growth (last year) | +46.39% |
| Earnings growth (this year) | +53.85% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.70 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SPHSSophiris Bio Inc | +0.31 | +63.27% |
| NVGNNovogen Ltd | -0.06 | -2.24% |
| BSPMBiostar Pharmaceutic... | -0.01 | -0.86% |
| CBLICleveland Biolabs In... | +0.09 | +2.74% |
Data as of 3:59pm ET, 02/27/2015
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$6.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Michael R. Bristow |
Chief Operating Officer Thomas A. Keuer |
Corporate headquarters Westminster, Colorado |
Forecasts
